Hyperlipidemia of diuretic therapy

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue SUPPL., 1998, Pages 23-27

  Ames, Richard ^a  

^a St Luke's Roosevelt Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; THIAZIDE DIURETIC AGENT;

CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; REVIEW; STROKE;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; CORONARY DISEASE; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERLIPIDEMIAS; HYPERTENSION; INDAPAMIDE; LONGITUDINAL STUDIES; META-ANALYSIS; SODIUM CHLORIDE SYMPORTER INHIBITORS; SYSTOLE;

EID: 0031714965     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Ames RP. Antihypertensive drugs and lipid profiles. Am J Hypertens 1988 ; 1 : 421-7.
2. Materson BJ, Reda DJ, Cushman WC et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993 ; 328 : 914-21.
3. The sixth report to the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997 ; 157 : 2413-46.
4. Lasser NL, Grandits G, Caggiula AW et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial. Am J Med 1984 ; 76 : 52-66.
5. Williams WR, Schneider KA, Borhani NO et al. The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants. Am J Prev Med 1986 ; 2 : 248-55.
6. Elliott WJ. Glucose and cholesterol elevations during thiazide therapy : intention-to-treat versus actual on-treatment experience. Am J Med 1995 ; 99 : 261-9.
7. Ames RP. Risk factors as they relate to drug therapy in hypertension. South African Med J 1989 ; 76 (October supplement) : 8-12.
8. Middeke M, Richter WO, Schwand P et al. Normalization of lipid metabolism after withdrawal from antihypertensive long-term therapy with beta-blockers and diuretics. Atherosclerosis 1990 ; 10 : 145-7.
9. Carlsen JE, Kober L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. Br Med J 1990 ; 300 : 975-8.
10. Burris JF, Weir MR, Oparil S et al. An assessment of diltiazem and hydrochlorothiazide in hypertension. JAMA 1990 ; 263 : 1507-12.
11. Ames RP. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am J Cardiol 1996 ; 77 (suppl B) : B 12 - B 16.
12. Grimm RH Jr, Flack JM, Grandits GA et al. For the treatment of Mild Hypertension Study (TOMHS) Research Group. Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 1996 ; 275 : 1549-56.
13. Grimm RH Jr, Leon AS, Hunninghake DB et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 1981 ; 94 : 7-11.
14. Oberman A, Wassertheil-Smoller S, Langford HG et al. Pharmacologic and nutritional treatment of mild hypertension : changes in cardiovascular risk status. Ann Intern Med 1990 ; 112 : 89-95.
15. Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents. JAMA 1997 ; 277 : 739-45.
16. Manton KG, Corder L, Stallard E. Chronic disability trends in elderly United States populations : 1982-1994. Proc Nat Acad Sci USA 1997 ; 94 : 2593-8.
17. Staessen J, Fagard R, Thijs L et al for the Systolic Hypertension-Europe Trial Investigators. Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet 1997 ; 360 : 757-64.
18. Estacio RO, Jeffers BW, Hiatt WR et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998 ; 338 : 645-52.
19. Dustan HP, Tarazi RC, Bravo EL. Dependence of arterial pressure on intravascular volume in treatment of hypertensive patients. N Engl J Med 1972 ; 286 : 861-6.
20. Yakovlevich M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991 ; 151 : 786-92.
21. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995 ; 333 : 1301-7.
22. Frick MH, Elo O, Haapa K et al. Helsinki heart study : primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia : safety of treatment, changes in risk factors, and incidence of coronary heart diseases. N Engl J Med 1987 ; 317 : 1237-45.
23. Canner PL, Berge KG, Wenger NK et al. Fifteen-year mortality in coronary drug project patients : long-term benefit with niacin. J Am Coll Cardiol 1986 ; 8 : 1245-55.
24. Adult treatment panel II. Summary of the second report of the National Cholesterol Education P rogram (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 1993 ; 269 : 3015-23.
25. Herbert PR, Gaziano GM, Chan KS, Hennekens CH. Cholesterol lowering with stating drugs, risk of stroke, and total mortality. JAMA 1997 ; 278 : 313-21.
26. Burt VL, Cutler JA, Higgins M et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population : data from the health examination surveys, 1960 to 1991. Hypertension 1995 ; 26 : 60-9.
27. McBride P, Schrott HG, Plane MB, Underbakke G, Brown RL. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med 1998 ; 158 : 1238-44.